Call our 24 hours, seven days a week helpline at 800.272.3900
Lecanemab is the second FDA-approved treatment that addresses the underlying biology of Alzheimer's and changes the course of the disease in a meaningful way for people in the early stages.
Cómo participar
Realice el paseo
Más información